enGene Holdings Inc (ENGN)
8.50
-2.00
(-19.05%)
USD |
NASDAQ |
May 31, 16:00
9.38
+0.88
(+10.35%)
After-Hours: 20:00
enGene Holdings Market Cap: 374.86M for May 31, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 31, 2024 | 374.86M |
| May 30, 2024 | 463.06M |
| May 29, 2024 | 561.85M |
| May 28, 2024 | 554.35M |
| May 24, 2024 | 567.14M |
| May 23, 2024 | 579.49M |
| May 22, 2024 | 583.01M |
| May 21, 2024 | 585.22M |
| May 20, 2024 | 558.76M |
| May 17, 2024 | 572.43M |
| May 16, 2024 | 625.79M |
| May 15, 2024 | 600.65M |
| May 14, 2024 | 628.00M |
| May 13, 2024 | 627.56M |
| May 10, 2024 | 627.56M |
| May 09, 2024 | 635.05M |
| May 08, 2024 | 640.35M |
| May 07, 2024 | 658.43M |
| May 06, 2024 | 683.12M |
| May 03, 2024 | 684.00M |
| May 02, 2024 | 675.63M |
| May 01, 2024 | 700.76M |
| April 30, 2024 | 701.20M |
| April 29, 2024 | 692.38M |
| April 26, 2024 | 683.56M |
| Date | Value |
|---|---|
| April 25, 2024 | 649.17M |
| April 24, 2024 | 650.49M |
| April 23, 2024 | 672.98M |
| April 22, 2024 | 652.69M |
| April 19, 2024 | 654.87M |
| April 18, 2024 | 624.91M |
| April 17, 2024 | 694.15M |
| April 16, 2024 | 687.97M |
| April 15, 2024 | 696.35M |
| April 12, 2024 | 679.18M |
| April 11, 2024 | 717.96M |
| April 10, 2024 | 695.03M |
| April 09, 2024 | 713.71M |
| April 08, 2024 | 717.23M |
| April 05, 2024 | 726.05M |
| April 04, 2024 | 722.96M |
| April 03, 2024 | 720.83M |
| April 02, 2024 | 736.52M |
| April 01, 2024 | 736.09M |
| March 28, 2024 | 738.70M |
| March 27, 2024 | 751.34M |
| March 26, 2024 | 784.46M |
| March 25, 2024 | 794.92M |
| March 22, 2024 | 783.59M |
| March 21, 2024 | 775.75M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
160.53M
Minimum
Dec 22 2023
794.92M
Maximum
Mar 25 2024
435.13M
Average
411.76M
Median
Market Cap Benchmarks
| Acasti Pharma Inc | 25.65M |
| Aurinia Pharmaceuticals Inc | 775.17M |
| Edesa Biotech Inc | 14.28M |
| Lexaria Bioscience Corp | 50.25M |
| InMed Pharmaceuticals Inc | 2.466M |
Market Cap Related Metrics
| Price to Book Value | 6.009 |
| Price | 8.50 |
| Earnings Yield | -54.12% |